Neutralization of IGF-I and-II ligands with the fully humanized bispecific monoclonal antibody xentuzumab inhibits AR-V7-induced enzalutamide resistance in castration-resistant prostate cancer

Category Primary study
JournalCancer Research
Year 2017
This article has no abstract
Epistemonikos ID: 6cb71ee6fcb1dddf12388ce9fe1137f5bddfdd78
First added on: Feb 08, 2025